Article Per Year (5 Year)
p-Index From 2019 - 2024
0.444
P-Index
This Author published in this journals
All Journal Jurnal Respirologi Indonesia Respiratory Science
Tri Wahju Astuti
Universitas Brawijaya
Health Professions Medicine & Pharmacology

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Increased Serum KL-6/MUC1 Level, Neutrophils and Lymphocytes Sputum in Malang Splendid Bird Market Workers Zam Zam Firmansyah; Tri Wahju Astuti; Garinda Alma Duta
Jurnal Respirologi Indonesia Vol 40, No 2 (2020)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v40i2.103

Abstract

Backgrounds: People who work in the bird market have a high exposure risk of air pollution in large numbers, particulate pollutans including organic dust, loose feathers, insects or ticks, food aerosol particles, bird’s excreta (amonia) and various of gram bacteria, fungal and virus. Exposure to particles will stimulate the immune system against harmful pathogens in the form of an inflammatory response. An infection or injury will stimulate secretion of KL-6/MUC1 (Krebs von den Lungen-6 is a high molecular weight, mucin-like glycoprotein in human (MUC1)) by AEC type II and bronchial epithelial cells in response to cell damage and regeneration. Methods: This was an observational analytic cross-sectional study on 35 subjects, which examined and analyzed the characteristics of workers, percentage count of neutrophils, lymphocytes in induced sputum and KL-6/MUC1 serum levels using ELISA sandwich. Results: Mean KL-6/MUC1 serum levels in the bird market workers increased (1152.67+583.92 U/ml) from normal levels (105.3-401.2 U/ml). There was a significant positive correlation between the length of exposure and KL-6/MUC1 serum levels (r=0.624; P
Association of Interleukin-2 (IL-2) Levels With Acid-Fast Bacillus (AFB) Sputum Conversion In Drug-Resistant Pulmonary Tuberculosis Patient Gede Sasmika Suwandi; Yani Jane Sugiri; Tri Wahju Astuti; Harun Al Rasyid
Respiratory Science Vol. 3 No. 1 (2022): Respiratory Science
Publisher : Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/respirsci.v3i1.52

Abstract

Background: Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis (Mtb) which can be found on multiple organs, but mostly infect the lung. AFB smear is used to diagnose and evaluate therapy response, to show bacterial burden and the patient’s infectious status. Combination of antituberculosis drugs for a long period of time could cause poor compliance and increased risk of resistance. Mtb infection induce immune response and release cytokines, one of which is interleukin-2 (IL-2) that regulate T lymphocyte cell. Higher IL-2 levels is found on patient with high bacterial burdern.  This study aims to see the assossciation between IL-2 levels before and 30 days after DR-TB treatment, to see pre and post-treatment IL-2 levels with conversion of AFB smear, and correlation between pre-treatment IL-2 levels and AFB smear. Method: This was a cohort prospective study at RSUD dr Saiful Anwar Malang. Thirty nine DR-TB patients underwent AFB smear before and 30 days after treatment, while IL-2 levels was also measured by Enzym-Linked Immunosorbent Assay (ELISA) technique. Results: The levels of IL-2 before treatment was significantly higher compared to 30 days after treatment (P<0.001). There was no significant IL-2 levels difference between conversion and non-conversion group (P=0.23), and a weak, not-significant correlation between IL-2 levels and AFB smear (r=0.28; P=0.06). Conclusion: The levels of IL-2 was significantly higher before than after treatment and it cannot be used to determine the positivity of acid-resistant bacilli smears in the sputum of patients with DR-TB. The limited timeframe and biomarker in this study raise the possibility to observe IL-2 as well as other biomarkers after intensive phase of TB treatment for future studies.
Co-Authors Garinda Alma Duta Gede Sasmika Suwandi Harun Al Rasyid Yani Jane Sugiri Zam Zam Firmansyah